TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs9263758
log Bayes Factor = 66.5762
Chromosome 6   position 31,115,874  (GRCh37) Explore rs9263758 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
E10.9 Without complications
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.000 1.000
E10-E14 Diabetes mellitus
0.000 0.000 1.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.000 1.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
E00-E07 Disorders of thyroid gland
0.000 0.000 1.000
E11.9 Without complications
0.000 0.000 1.000
E03 Other hypothyroidism
0.000 0.000 1.000
E83.1 Disorders of iron metabolism
1.000 0.000 0.000
E11 Non-insulin-dependent diabetes mellitus
0.000 0.000 1.000
E78.0 Pure hypercholesterolaemia
0.000 0.001 0.999
G35 Multiple sclerosis
0.998 0.002 0.000
E05.9 Thyrotoxicosis, unspecified
0.000 0.002 0.998
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.003 0.997
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.005 0.995
E14 Unspecified diabetes mellitus
0.000 0.006 0.994
E70-E90 Metabolic disorders
0.000 0.009 0.991
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.018 0.982
E16 Other disorders of pancreatic internal secretion
0.000 0.031 0.969
E16.2 Hypoglycaemia, unspecified
0.000 0.047 0.953
E14.9 Without complications
0.000 0.047 0.953
E10.3 With ophthalmic complications
0.000 0.056 0.944
C83.3 Large cell (diffuse)
0.000 0.058 0.942
E14.3 With ophthalmic complications
0.000 0.079 0.921
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.101 0.899
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.000 0.106 0.894
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.107 0.893
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.000 0.107 0.893
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.108 0.892
C85.1 B-cell lymphoma, unspecified
0.000 0.124 0.876
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.127 0.873
L40.9 Psoriasis, unspecified
0.000 0.129 0.871
E11.0 With coma
0.000 0.138 0.862
E10.1 With ketoacidosis
0.000 0.141 0.859
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.146 0.854
E11.1 With ketoacidosis
0.000 0.162 0.838
E78.2 Mixed hyperlipidaemia
0.000 0.167 0.833
E40-E46 Malnutrition
0.000 0.176 0.824
E83 Disorders of mineral metabolism
0.809 0.178 0.014
E14.5 With peripheral circulatory complications
0.000 0.194 0.806
E07 Other disorders of thyroid
0.000 0.197 0.802
E13 Other specified diabetes mellitus
0.000 0.198 0.802
E10.8 With unspecified complications
0.000 0.199 0.800
E10.6 With other specified complications
0.000 0.204 0.796
G35-G37 Demyelinating diseases of the central nervous system
0.790 0.210 0.000
E74 Other disorders of carbohydrate metabolism
0.000 0.210 0.789
E78.4 Other hyperlipidaemia
0.000 0.216 0.784
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.216 0.784
E14.6 With other specified complications
0.000 0.218 0.782
E14.4 With neurological complications
0.000 0.224 0.775
E79 Disorders of purine and pyrimidine metabolism
0.000 0.227 0.773
E16.1 Other hypoglycaemia
0.000 0.228 0.772
E14.1 With ketoacidosis
0.000 0.229 0.771
E78.5 Hyperlipidaemia, unspecified
0.000 0.241 0.759
E10.0 With coma
0.000 0.241 0.759
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.248 0.752
E78.8 Other disorders of lipoprotein metabolism
0.000 0.253 0.747
E78.1 Pure hyperglyceridaemia
0.000 0.253 0.747
G37 Other demyelinating diseases of central nervous system
0.742 0.258 0.000
E83.3 Disorders of phosphorus metabolism
0.729 0.268 0.003
C82.2 Large cell, follicular
0.000 0.271 0.729
E11.2 With renal complications
0.000 0.274 0.726
C84 Peripheral and cutaneous T-cell lymphomas
0.000 0.276 0.724
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.000 0.277 0.723
E78.6 Lipoprotein deficiency
0.000 0.282 0.718
E03.8 Other specified hypothyroidism
0.000 0.282 0.718
E10.7 With multiple complications
0.000 0.283 0.717
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.717
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.717
E12 Malnutrition-related diabetes mellitus
0.000 0.283 0.717
E03.5 Myxoedema coma
0.000 0.283 0.717
E03.4 Atrophy of thyroid (acquired)
0.000 0.283 0.717
E03.3 Postinfectious hypothyroidism
0.000 0.283 0.717
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.283 0.717
E11.7 With multiple complications
0.000 0.283 0.717
E05.5 Thyroid crisis or storm
0.000 0.285 0.715
E05.4 Thyrotoxicosis factitia
0.000 0.285 0.715
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.285 0.715
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.285 0.715
E14.7 With multiple complications
0.000 0.287 0.713
E14.0 With coma
0.000 0.287 0.713
E77 Disorders of glycoprotein metabolism
0.000 0.290 0.710
E76 Disorders of glycosaminoglycan metabolism
0.000 0.290 0.710
E72 Other disorders of amino-acid metabolism
0.000 0.290 0.710
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.290 0.710
E70 Disorders of aromatic amino-acid metabolism
0.000 0.290 0.710
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.290 0.710
E11.8 With unspecified complications
0.000 0.293 0.707
E15 Nondiabetic hypoglycaemic coma
0.000 0.296 0.704
G37.9 Demyelinating disease of central nervous system, unspecified
0.702 0.298 0.000
C83.7 Burkitt's tumour
0.000 0.299 0.700
E84 Cystic fibrosis
0.000 0.301 0.699
E14.2 Withrenal complications
0.000 0.301 0.698
E46 Unspecified protein-energy malnutrition
0.000 0.302 0.698
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.305 0.695
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.305 0.695
E16.4 Abnormal secretion of gastrin
0.000 0.305 0.695
E16.3 Increased secretion of glucagon
0.000 0.305 0.695
C82.3 Follicular lymphoma grade IIIa
0.000 0.307 0.693
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.309 0.691
C82.0 Small cleaved cell, follicular
0.000 0.324 0.676
E14.8 With unspecified complications
0.000 0.327 0.673
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.327 0.673
E11.5 With peripheral circulatory complications
0.000 0.328 0.672
E13.9 Without complications
0.000 0.331 0.669
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.331 0.669
E83.9 Disorder of mineral metabolism, unspecified
0.658 0.334 0.008
C86 Other specified types of T/NK-cell lymphoma
0.000 0.341 0.659
E88 Other metabolic disorders
0.000 0.353 0.647
C83.6 Undifferentiated (diffuse)
0.000 0.355 0.645
C83.5 Lymphoblastic (diffuse)
0.000 0.355 0.645
C83.4 Immunoblastic (diffuse)
0.000 0.355 0.645
C83.2 Mixed small and large cell (diffuse)
0.000 0.355 0.645
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.359 0.641
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.359 0.640
C85.0 Lymphosarcoma
0.000 0.359 0.640
C82.6 Cutaneous follicle centre lymphoma
0.000 0.360 0.640
C82.5 Diffuse follicle centre lymphoma
0.000 0.360 0.640
E07.9 Disorder of thyroid, unspecified
0.000 0.362 0.638
E10.5 With peripheral circulatory complications
0.000 0.366 0.633
E10.4 With neurological complications
0.000 0.367 0.633
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.377 0.622
E03.1 Congenital hypothyroidism without goitre
0.000 0.377 0.622
K90 Intestinal malabsorption
0.000 0.378 0.622
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.382 0.618
E78.3 Hyperchylomicronaemia
0.000 0.383 0.617
E07.8 Other specified disorders of thyroid
0.000 0.392 0.607
E05.8 Other thyrotoxicosis
0.000 0.393 0.607
E80.6 Other disorders of bilirubin metabolism
0.000 0.402 0.598
E80.2 Other porphyria
0.000 0.405 0.595
G36 Other acute disseminated demyelination
0.594 0.406 0.000
C94 Other leukaemias of specified cell type
0.000 0.408 0.592
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.409 0.591
E45 Retarded development following protein-energy malnutrition
0.000 0.409 0.591
E43 Unspecified severe protein-energy malnutrition
0.000 0.409 0.591
E42 Marasmic kwashiorkor
0.000 0.409 0.591
E41 Nutritional marasmus
0.000 0.409 0.591
E40 Kwashiorkor
0.000 0.409 0.591
G37.8 Other specified demyelinating diseases of central nervous system
0.590 0.410 0.000
E83.8 Other disorders of mineral metabolism
0.580 0.410 0.010
E83.2 Disorders of zinc metabolism
0.580 0.410 0.010
E83.0 Disorders of copper metabolism
0.580 0.410 0.010
C82.4 Follicular lymphoma grade IIIb
0.000 0.416 0.584
C84.0 Mycosis fungoides
0.000 0.420 0.580
E10.2 With renal complications
0.000 0.422 0.577
C85.7 Other specified types of non-Hodgkin's lymphoma
0.000 0.423 0.577
E07.1 Dyshormogenetic goitre
0.000 0.425 0.575
E07.0 Hypersecretion of calcitonin
0.000 0.425 0.575
E13.8 With unspecified complications
0.000 0.425 0.575
E13.7 With multiple complications
0.000 0.425 0.575
E13.6 With other specified complications
0.000 0.425 0.575
E13.5 With peripheral circulatory complications
0.000 0.425 0.575
E13.4 With neurological complications
0.000 0.425 0.575
E13.2 With renal complications
0.000 0.425 0.575
E13.1 With ketoacidosis
0.000 0.425 0.575
E13.0 With coma
0.000 0.425 0.575
E80.1 Porphyria cutanea tarda
0.000 0.428 0.572
E80.4 Gilbert's syndrome
0.000 0.433 0.567
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.434 0.566
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.434 0.566
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.434 0.566
E74.2 Disorders of galactose metabolism
0.000 0.434 0.566
E74.1 Disorders of fructose metabolism
0.000 0.434 0.566
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.438 0.562
E80.5 Crigler-Najjar syndrome
0.000 0.438 0.562
E80.3 Defects of catalase and peroxydase
0.000 0.438 0.562
E80.0 Hereditary erythropoietic porphyria
0.000 0.438 0.562
E13.3 With ophthalmic complications
0.000 0.440 0.560
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.445 0.554
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.445 0.554
E79.1 Lesch-Nyhan syndrome
0.000 0.445 0.554
C93 Monocytic leukaemia
0.000 0.454 0.545
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.455 0.545
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.459 0.541
C84.4 Peripheral T-cell lymphoma
0.000 0.462 0.538
G37.5 Concentric sclerosis [Balo]
0.532 0.468 0.000
G37.4 Subacute necrotising myelitis
0.532 0.468 0.000
G37.2 Central pontine myelinolysis
0.532 0.468 0.000
G37.1 Central demyelination of corpus callosum
0.532 0.468 0.000
G37.0 Diffuse sclerosis
0.532 0.468 0.000
C84.5 Other and unspecified T-cell lymphomas
0.000 0.468 0.532
C88 Malignant immunoproliferative diseases
0.001 0.468 0.531
C83.1 Small cleaved cell (diffuse)
0.000 0.476 0.524
E73 Lactose intolerance
0.001 0.479 0.520
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.480 0.520
C84.9 Mature T/NK-cell lymphoma, unspecified
0.000 0.481 0.519
C84.8 Cutaneous T-cell lymphoma, unspecified
0.000 0.481 0.519
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.000 0.481 0.519
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.000 0.481 0.519
C84.3 Lymphoepithelioid lymphoma
0.000 0.481 0.519
C84.2 T-zone lymphoma
0.000 0.481 0.519
C84.1 Sezary's diease
0.000 0.481 0.519
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
E12.9 Without complications
0.000 0.486 0.514
E12.8 With unspecified complications
0.000 0.486 0.514
E12.7 With multiple complications
0.000 0.486 0.514
E12.6 With other specified complications
0.000 0.486 0.514
E12.5 With peripheral circulatory complications
0.000 0.486 0.514
E12.4 With neurological complications
0.000 0.486 0.514
E12.3 With ophthalmic complications
0.000 0.486 0.514
E12.2 With renal complications
0.000 0.486 0.514
E12.1 With ketoacidosis
0.000 0.486 0.514
E12.0 With coma
0.000 0.486 0.514
E74.0 Glycogen storage disease
0.000 0.487 0.513
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.491 0.509
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.491 0.509
E70.3 Albinism
0.000 0.491 0.509
E70.2 Disorders of tyrosine metabolism
0.000 0.491 0.509
E70.1 Other hyperphenylalaninaemias
0.000 0.491 0.509
E70.0 Classical phenylketonuria
0.000 0.491 0.509
E71.3 Disorders of fatty-acid metabolism
0.000 0.491 0.509
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.491 0.509
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.491 0.509
E71.0 Maple-syrup-urine disease
0.000 0.491 0.509
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.491 0.509
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.491 0.509
E72.5 Disorders of glycine metabolism
0.000 0.491 0.509
E72.4 Disorders of ornithine metabolism
0.000 0.491 0.509
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.491 0.509
E72.2 Disorders of urea cycle metabolism
0.000 0.491 0.509
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.491 0.509
E72.0 Disorders of amino-acid transport
0.000 0.491 0.509
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.491 0.509
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.491 0.509
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.491 0.509
E76.2 Other mucopolysaccharidoses
0.000 0.491 0.509
E76.1 Mucopolysaccharidosis, type II
0.000 0.491 0.509
E76.0 Mucopolysaccharidosis, type I
0.000 0.491 0.509
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.491 0.509
E77.8 Other disorders of glycoprotein metabolism
0.000 0.491 0.509
E77.1 Defects in glycoprotein degradation
0.000 0.491 0.509
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.491 0.509
E83.4 Disorders of magnesium metabolism
0.501 0.496 0.004
C81 Hodgkin's disease
0.000 0.498 0.502
E84.8 Cystic fibrosis with other manifestations
0.000 0.498 0.501
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.498 0.501
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.498 0.501
E88.8 Other specified metabolic disorders
0.000 0.500 0.500
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.500 0.499
E88.2 Lipomatosis, not elsewhere classified
0.000 0.502 0.498
E84.9 Cystic fibrosis, unspecified
0.000 0.509 0.490
C86.5 Angioimmunoblastic T-cell lymphoma
0.000 0.510 0.490
E11.6 With other specified complications
0.000 0.510 0.489
K90.9 Intestinal malabsorption, unspecified
0.000 0.510 0.490
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system
0.489 0.511 0.000
E11.4 With neurological complications
0.000 0.512 0.488
E75.6 Lipid storage disorder, unspecified
0.000 0.520 0.479
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.520 0.479
E75.3 Sphingolipidosis, unspecified
0.000 0.520 0.479
E75.2 Other sphingolipidosis
0.000 0.520 0.479
E75.1 Other gangliosidosis
0.000 0.520 0.479
E75.0 GM2 gangliosidosis
0.000 0.520 0.479
E88.3 Tumour lysis syndrome
0.000 0.527 0.473
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.000 0.527 0.472
C86.4 Blastic NK-cell lymphoma
0.000 0.527 0.472
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.000 0.527 0.472
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.000 0.527 0.472
C86.1 Hepatosplenic T-cell lymphoma
0.000 0.527 0.472
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.000 0.527 0.472
C82.1 Mixed small cleaved and large cell, follicular
0.000 0.528 0.472
E88.9 Metabolic disorder, unspecified
0.000 0.536 0.464
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.536 0.464
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.540 0.459
C96.8 Histiocytic sarcoma
0.000 0.540 0.459
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.540 0.459
C96.6 Unifocal Langerhans-cell histiocytosis
0.000 0.540 0.459
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.000 0.540 0.459
C96.4 Sarcoma of dendritic cells (accessory cells)
0.000 0.540 0.459
C96.3 True histiocytic lymphoma
0.000 0.540 0.459
C96.2 Malignant mast cell tumour
0.000 0.540 0.459
C96.1 Malignant histiocytosis
0.000 0.540 0.459
C96.0 Letterer-Siwe disease
0.000 0.540 0.459
G36.0 Neuromyelitis optica [Devic]
0.453 0.547 0.000
K90.3 Pancreatic steatorrhoea
0.000 0.554 0.446
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.554 0.446
K90.1 Tropical sprue
0.000 0.554 0.446
L40 Psoriasis
0.000 0.558 0.442
C83.0 Small cell (diffuse)
0.000 0.559 0.441
E75.5 Other lipid storage disorders
0.000 0.562 0.438
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.562 0.438
K90.8 Other intestinal malabsorption
0.000 0.567 0.433
E11.3 With ophthalmic complications
0.000 0.570 0.430
G36.9 Acute disseminated demyelination, unspecified
0.426 0.574 0.000
G36.8 Other specified acute disseminated demyelination
0.426 0.574 0.000
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]
0.426 0.574 0.000
C94.7 Other specified leukaemias
0.000 0.575 0.424
C94.5 Acute myelofibrosis
0.000 0.575 0.424
C94.4 Acute panmyelosis
0.000 0.575 0.424
C94.3 Mast cell leukaemia
0.000 0.575 0.424
C94.2 Acute megakaryoblastic leukaemia
0.000 0.575 0.424
C94.1 Chronic erythraemia
0.000 0.575 0.424
C94.0 Acute erythraemia and erythroleukaemia
0.000 0.575 0.424
E44.1 Mild protein-energy malnutrition
0.000 0.576 0.424
E44.0 Moderate protein-energy malnutrition
0.000 0.576 0.424
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.000 0.580 0.420
C95 Leukaemia of unspecified cell type
0.001 0.586 0.413
C91 Lymphoid leukaemia
0.001 0.587 0.412
E89.4 Postprocedural ovarian failure
0.000 0.587 0.413
E83.5 Disorders of calcium metabolism
0.407 0.592 0.001
E85 Amyloidosis
0.001 0.598 0.401
E06 Thyroiditis
0.000 0.600 0.400
I25.1 Atherosclerotic heart disease
0.000 0.605 0.395
I25 Chronic ischaemic heart disease
0.000 0.606 0.394
C93.9 Monocytic leukaemia, unspecified
0.000 0.608 0.391
C93.7 Other monocytic leukaemia
0.000 0.608 0.391
C93.3 Juvenile myelomonocytic leukaemia
0.000 0.608 0.391
C93.2 Subacute monocytic leukaemia
0.000 0.608 0.391
C93.0 Acute monocytic leukaemia
0.000 0.608 0.391
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.609 0.391
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.609 0.391
E89.5 Postprocedural testicular hypofunction
0.000 0.609 0.391
E89.1 Postprocedural hypoinsulinaemia
0.000 0.609 0.391
E89.3 Postprocedural hypopituitarism
0.000 0.610 0.390
C88.9 Malignant immunoproliferative disease, unspecified
0.001 0.619 0.381
C88.7 Other malignant immunoproliferative diseases
0.001 0.619 0.381
C88.3 Immunoproliferative small intestinal disease
0.001 0.619 0.381
C88.2 Gamma heavy chain disease
0.001 0.619 0.381
C88.1 Alpha heavy chain disease
0.001 0.619 0.381
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.000 0.624 0.375
E73.8 Other lactose intolerance
0.001 0.626 0.373
E73.1 Secondary lactase deficiency
0.001 0.626 0.373
E73.0 Congenital lactase deficiency
0.001 0.626 0.373
I25.5 Ischaemic cardiomyopathy
0.000 0.630 0.370
C92 Myeloid leukaemia
0.000 0.632 0.368
I25.2 Old myocardial infarction
0.000 0.637 0.363
C81.0 Lymphocytic predominance
0.000 0.639 0.361
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.000 0.640 0.360
C81.3 Lymphocytic depletion
0.000 0.640 0.360
C91.9 Lymphoid leukaemia, unspecified
0.000 0.640 0.360
L40.8 Other psoriasis
0.000 0.642 0.358
E89.2 Postprocedural hypoparathyroidism
0.000 0.647 0.352
I25.0 Atherosclerotic cardiovascular disease, so described
0.000 0.648 0.352
C81.7 Other Hodgkin's disease
0.000 0.649 0.350
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.652 0.348
C81.2 Mixed cellularity
0.000 0.655 0.345
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.001 0.657 0.342
E65-E68 Obesity and other hyperalimentation
0.000 0.658 0.342
C81.9 Hodgkin's disease, unspecified
0.000 0.669 0.331
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.673 0.327
I20-I25 Ischaemic heart diseases
0.000 0.675 0.325
L40.1 Generalised pustular psoriasis
0.000 0.676 0.324
L40.4 Guttate psoriasis
0.000 0.678 0.321
L40.2 Acrodermatitis continua
0.000 0.683 0.317
I22 Subsequent myocardial infarction
0.000 0.684 0.316
M06.9 Rheumatoid arthritis, unspecified
0.000 0.688 0.312
I22.1 Subsequent myocardial infarction of inferior wall
0.000 0.689 0.311
L40.0 Psoriasis vulgaris
0.000 0.694 0.306
C81.1 Nodular sclerosis
0.000 0.696 0.304
I25.9 Chronic ischaemic heart disease, unspecified
0.000 0.701 0.299
E06.5 Other chronic thyroiditis
0.000 0.703 0.297
C95.7 Other leukaemia of unspecified cell type
0.001 0.703 0.296
C95.2 Subacute leukaemia of unspecified cell type
0.001 0.703 0.296
C93.1 Chronic monocytic leukaemia
0.001 0.704 0.296
C91.8 Mature B-cell leukaemia Burkitt-type
0.001 0.704 0.296
C91.7 Other lymphoid leukaemia
0.001 0.704 0.296
C91.6 Prolymphocytic leukaemia of T-cell type
0.001 0.704 0.296
C91.3 Prolymphocytic leukaemia
0.001 0.704 0.296
C91.2 Subacute lymphocytic leukaemia
0.001 0.704 0.296
E85.2 Heredofamilial amyloidosis, unspecified
0.001 0.712 0.288
E85.1 Neuropathic heredofamilial amyloidosis
0.001 0.712 0.288
E85.0 Nonneuropathic heredofamilial amyloidosis
0.001 0.712 0.288
E06.4 Drug-induced thyroiditis
0.000 0.713 0.287
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.713 0.287
E06.0 Acute thyroiditis
0.000 0.713 0.287
C91.5 Adult T-cell leukaemia
0.001 0.715 0.284
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.716 0.284
I25.6 Silent myocardial ischaemia
0.000 0.718 0.282
L40.3 Pustulosis palmaris et plantaris
0.000 0.731 0.269
E85.8 Other amyloidosis
0.001 0.732 0.267
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.732 0.267
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.000 0.734 0.266
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.000 0.736 0.264
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.000 0.736 0.264
C92.5 Acute myelomonocytic leukaemia
0.000 0.736 0.264
C92.3 Myeloid sarcoma
0.000 0.736 0.264
C92.2 Subacute myeloid leukaemia
0.000 0.736 0.264
I25.8 Other forms of chronic ischaemic heart disease
0.000 0.737 0.263
C92.7 Other myeloid leukaemia
0.000 0.741 0.259
C92.9 Myeloid leukaemia, unspecified
0.000 0.742 0.258
C95.1 Chronic leukaemia of unspecified cell type
0.001 0.742 0.257
I23 Certain current complications following acute myocardial infarction
0.000 0.743 0.257
I25.4 Coronary artery aneurysm
0.000 0.743 0.257
C92.1 Chronic myeloid leukaemia
0.000 0.745 0.254
E06.1 Subacute thyroiditis
0.000 0.745 0.254
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.000 0.746 0.254
L40.5 Arthropathic psoriasis
0.000 0.747 0.253
C91.1 Chronic lymphocytic leukaemia
0.000 0.749 0.251
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.750 0.250
I24 Other acute ischaemic heart diseases
0.000 0.750 0.250
C92.4 Acute promyelocytic leukaemia
0.000 0.751 0.249
I20 Angina pectoris
0.000 0.751 0.249
E20-E35 Disorders of other endocrine glands
0.000 0.754 0.246
E67 Other hyperalimentation
0.000 0.755 0.245
E68 Sequelae of hyperalimentation
0.000 0.755 0.245
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.000 0.755 0.245
E85.4 Organ-limited amyloidosis
0.001 0.755 0.244
I20.9 Angina pectoris, unspecified
0.000 0.756 0.244
E85.9 Amyloidosis, unspecified
0.001 0.758 0.242
C95.9 Leukaemia, unspecified
0.001 0.758 0.241
I22.8 Subsequent myocardial infarction of other sites
0.000 0.761 0.239
I24.9 Acute ischaemic heart disease, unspecified
0.000 0.761 0.239
C95.0 Acute leukaemia of unspecified cell type
0.001 0.762 0.238
E50-E64 Other nutritional deficiencies
0.000 0.764 0.236
C90 Multiple myeloma and malignant plasma cell neoplasms
0.029 0.772 0.199
E28 Ovarian dysfunction
0.000 0.772 0.227
C91.0 Acute lymphoblastic leukaemia
0.001 0.775 0.224
L40-L45 Papulosquamous disorders
0.000 0.778 0.222
E28.2 Polycystic ovarian syndrome
0.000 0.778 0.222
I22.9 Subsequent myocardial infarction of unspecified site
0.000 0.778 0.222
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.000 0.781 0.219
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.000 0.781 0.219
E85.3 Secondary systemic amyloidosis
0.001 0.783 0.216
M06.98 Rheumatoid arthritis, unspecified (Other)
0.000 0.786 0.214
I25.3 Aneurysm of heart
0.000 0.788 0.212
I23.8 Other current complications following acute myocardial infarction
0.000 0.791 0.209
I22.0 Subsequent myocardial infarction of anterior wall
0.000 0.792 0.208
E06.9 Thyroiditis, unspecified
0.001 0.800 0.199
E06.3 Autoimmune thyroiditis
0.000 0.807 0.193
E65 Localised adiposity
0.000 0.811 0.189
E24 Cushing's syndrome
0.000 0.811 0.188
I20.1 Angina pectoris with documented spasm
0.000 0.813 0.187
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction
0.000 0.815 0.185
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction
0.000 0.815 0.185
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction
0.000 0.815 0.185
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction
0.000 0.815 0.185
I23.2 Ventricular septal defect as current complication following acute myocardial infarction
0.000 0.815 0.185
I23.1 Atrial septal defect as current complication following acute myocardial infarction
0.000 0.815 0.185
I23.0 Haemopericardium as current complication following acute myocardial infarction
0.000 0.815 0.185
E73.9 Lactose intolerance, unspecified
0.001 0.816 0.183
C88.0 Waldenstrom's macroglobulinaemia
0.001 0.817 0.181
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.823 0.176
E32 Diseases of thymus
0.000 0.823 0.176
E31 Polyglandular dysfunction
0.000 0.823 0.176
E30 Disorders of puberty, not elsewhere classified
0.000 0.823 0.176
E25 Adrenogenital disorders
0.000 0.823 0.176
E67.8 Other specified hyperalimentation
0.000 0.824 0.176
E67.3 Hypervitaminosis D
0.000 0.824 0.176
E67.2 Megavitamin-B6 syndrome
0.000 0.824 0.176
E67.1 Hypercarotenaemia
0.000 0.824 0.176
E67.0 Hypervitaminosis A
0.000 0.824 0.176
M06 Other rheumatoid arthritis
0.000 0.824 0.176
E26 Hyperaldosteronism
0.000 0.826 0.174
L43 Lichen planus
0.000 0.827 0.173
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.828 0.171
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.830 0.169
E63 Other nutritional deficiencies
0.000 0.830 0.169
E50 Vitamin A deficiency
0.000 0.830 0.169
E60 Dietary zinc deficiency
0.000 0.830 0.169
E59 Dietary selenium deficiency
0.000 0.830 0.169
E54 Ascorbic acid deficiency
0.000 0.830 0.169
E52 Niacin deficiency [pellagra]
0.000 0.830 0.169
E56 Other vitamin deficiencies
0.000 0.831 0.169
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.000 0.831 0.168
L42 Pityriasis rosea
0.000 0.834 0.166
E28.9 Ovarian dysfunction, unspecified
0.000 0.837 0.163
E28.8 Other ovarian dysfunction
0.000 0.837 0.163
E28.1 Androgen excess
0.000 0.837 0.163
E28.0 Oestrogen excess
0.000 0.837 0.163
C90.1 Plasma cell leukaemia
0.020 0.837 0.143
C90.3 Solitary plasmacytoma
0.020 0.839 0.140
L44 Other papulosquamous disorders
0.000 0.840 0.160
L41 Parapsoriasis
0.000 0.840 0.160
L45 Papulosquamous disorders in diseases classified elsewhere
0.000 0.840 0.160
E51 Thiamine deficiency
0.000 0.842 0.157
M06.3 Rheumatoid nodule
0.000 0.844 0.156
E58 Dietary calcium deficiency
0.000 0.845 0.154
L43.9 Lichen planus, unspecified
0.000 0.851 0.149
E61 Deficiency of other nutrient elements
0.000 0.852 0.147
E24.9 Cushing's syndrome, unspecified
0.000 0.853 0.147
E20 Hypoparathyroidism
0.000 0.854 0.146
E21.3 Hyperparathyroidism, unspecified
0.000 0.855 0.145
I24.1 Dressler's syndrome
0.000 0.857 0.143
M06.4 Inflammatory polyarthropathy
0.000 0.861 0.139
E29 Testicular dysfunction
0.000 0.861 0.138
E24.2 Drug-induced Cushing's syndrome
0.000 0.864 0.136
E23 Hypofunction and other disorders of pituitary gland
0.000 0.864 0.136
M06.32 Rheumatoid nodule (Upper arm)
0.000 0.864 0.136
E24.8 Other Cushing's syndrome
0.000 0.865 0.135
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.865 0.135
E24.3 Ectopic ACTH syndrome
0.000 0.865 0.135
E24.1 Nelson's syndrome
0.000 0.865 0.135
E24.0 Pituitary-dependent Cushing's disease
0.000 0.865 0.135
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.865 0.135
I24.8 Other forms of acute ischaemic heart disease
0.000 0.865 0.135
M06.34 Rheumatoid nodule (Hand)
0.000 0.868 0.132
E25.9 Adrenogenital disorder, unspecified
0.000 0.873 0.127
E25.8 Other adrenogenital disorders
0.000 0.873 0.127
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.873 0.127
E30.9 Disorder of puberty, unspecified
0.000 0.873 0.127
E30.8 Other disorders of puberty
0.000 0.873 0.127
E30.1 Precocious puberty
0.000 0.873 0.127
E30.0 Delayed puberty
0.000 0.873 0.127

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.